This inventor holds 3 USPTO granted patents. Top assignees: Bristol-Myers Company, Other. Active years: 1991-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Meriden, CT (US) (1991)
- Chapel, NC (US) (1992)
- Chapel Hill, NC (US) (1993)
Company Filing History:

Years Active: 1991-1993
Title: William L Christopher: Innovator in Psychotropic Compounds
Introduction
William L Christopher is a notable inventor based in Meriden, CT (US). He has made significant contributions to the field of psychotropic compounds, holding a total of 3 patents. His work focuses on developing innovative derivatives that serve as antipsychotic and anxiolytic agents.
Latest Patents
Among his latest patents, Christopher has developed psychotropic heterobicycloalkylpiperazine derivatives. These compounds possess a unique structure wherein V is a 3- or 4-membered unsaturated chain, containing all carbon atoms when 4-membered, or when a 3-membered chain, V contains an oxygen or sulfur atom as one of the members. R can be H or C1-4 alkyl, while W and X represent various chemical components. These compounds are particularly useful as antipsychotic and/or anxiolytic agents. Another significant patent includes 4-(4-Piperidinyl-thieno[3,2-c]pyridine derivatives of n-alkylglutarimides. These novel derivatives are designed to be effective antipsychotic agents with reduced side-effect liability.
Career Highlights
Throughout his career, Christopher has worked with various companies, including Bristol-Myers Company. His innovative research has led to advancements in the pharmaceutical industry, particularly in the development of psychotropic medications.
Collaborations
Christopher has collaborated with notable individuals in his field, including his coworker James S New. Their joint efforts have contributed to the success of their research and the development of new compounds.
Conclusion
William L Christopher's contributions to the field of psychotropic compounds highlight his innovative spirit and dedication to improving mental health treatments. His patents reflect a commitment to advancing pharmaceutical science and enhancing the efficacy of antipsychotic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile